Who
Annalisa Jenkins
Director
Company insider
Files Form 4 as: Director, Skye Bioscience; Director, Mereo BioPharma Group; Director, COMPASS Pathways; Director, Tectonic Therapeutic; Director, Serina Therapeutics; Director, Ardelyx; President and CEO, Dimension Therapeutics; Director, Oncosec Medical.
In numbers
- Trades disclosed
- 51
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $42K
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 20 Apr 2015
- Last trade
- 31 Mar 2026
- Last filed
- 2 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —106,848 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —106,848 | filing |
| 6 Feb 2026filed 9 Feb 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 5 Feb 2025filed 6 Feb 2025 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 5 Feb 2025filed 6 Feb 2025 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,243 | filing |
| 28 Oct 2024filed 30 Oct 2024 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 1 Aug 2024filed 5 Aug 2024 | CMPS COMPASS PathwaysBiotechnology | SEC FORM 4 Code F | $1,108161 at $6.88 | filing |
| 9 May 2024filed 13 May 2024 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 1 May 2024filed 3 May 2024 | CMPS COMPASS PathwaysBiotechnology | SEC FORM 4 Code F | $1,789211 at $8.48 | filing |
| 29 Feb 2024filed 4 Mar 2024 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 8 Feb 2024filed 9 Feb 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 8 Feb 2024filed 9 Feb 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,947 | filing |
| 1 Feb 2024filed 5 Feb 2024 | CMPS COMPASS PathwaysBiotechnology | SEC FORM 4 Code F | $1,985175 at $11.34 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.